Sichuan Hebang Biotechnology Corporation Limited
603077.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥17 | CN¥21 | CN¥26 | CN¥29 |
| - Cash | CN¥7 | CN¥3 | CN¥5 | CN¥2 |
| + Debt | CN¥7 | CN¥2 | CN¥2 | CN¥1 |
| Enterprise Value | CN¥17 | CN¥19 | CN¥24 | CN¥28 |
| Revenue | CN¥9 | CN¥9 | CN¥13 | CN¥10 |
| % Growth | -3.1% | -32.3% | 30.6% | – |
| Gross Profit | CN¥1 | CN¥2 | CN¥6 | CN¥4 |
| % Margin | 6.3% | 22.7% | 42.5% | 41.2% |
| EBITDA | CN¥1 | CN¥2 | CN¥5 | CN¥4 |
| % Margin | 10.8% | 27.3% | 41.4% | 42.9% |
| Net Income | CN¥0 | CN¥1 | CN¥4 | CN¥3 |
| % Margin | 0.4% | 14.5% | 29.2% | 30.2% |
| EPS Diluted | 0.004 | 0.147 | 0.438 | 0.358 |
| % Growth | -97.5% | -66.3% | 22.3% | – |
| Operating Cash Flow | CN¥0 | CN¥0 | CN¥3 | CN¥3 |
| Capital Expenditures | -CN¥1 | -CN¥1 | -CN¥1 | -CN¥2 |
| Free Cash Flow | -CN¥1 | -CN¥1 | CN¥2 | CN¥1 |